Published in Proc Natl Acad Sci U S A on May 15, 1993
A small element from the Mason-Pfizer monkey virus genome makes human immunodeficiency virus type 1 expression and replication Rev-independent. Proc Natl Acad Sci U S A (1994) 4.43
Human immunodeficiency viruses regulated by alternative trans-activators: genetic evidence for a novel non-transcriptional function of Tat in virion infectivity. EMBO J (1994) 1.78
Genetic instability of live, attenuated human immunodeficiency virus type 1 vaccine strains. J Virol (1999) 1.37
Genetic analysis of HIV-1 subtypes in Nairobi, Kenya. PLoS One (2008) 1.00
Genetically simpler bovine leukemia virus derivatives can replicate independently of Tax and Rex. J Virol (1995) 0.96
In vivo study of genetically simplified bovine leukemia virus derivatives that lack tax and rex. J Virol (1997) 0.92
Inhibitory activity of the equine infectious anemia virus major 5' splice site in the absence of Rev. J Virol (1996) 0.82
Construction and in vitro properties of a series of attenuated simian immunodeficiency viruses with all accessory genes deleted. J Virol (2001) 0.81
Bovine leukemia virus structural gene vectors are immunogenic and lack pathogenicity in a rabbit model. J Virol (1999) 0.81
Long-term infection with retroviral structural gene vector provides protection against bovine leukemia virus disease in rabbits. Virology (2004) 0.76
The IDDM-associated solitary retroviral promoters DQ-LTR3 and DQ-LTR13 have a distinct impact on the expression of selected DQB1 genes in different cell lines in vitro. Immunogenetics (2003) 0.75
Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene. Science (1992) 9.30
Antigenic diversity thresholds and the development of AIDS. Science (1991) 5.13
Human immunodeficiency virus-like particles produced by a vaccinia virus expression vector. Proc Natl Acad Sci U S A (1989) 4.26
Mutational inactivation of an inhibitory sequence in human immunodeficiency virus type 1 results in Rev-independent gag expression. J Virol (1992) 3.14
The biochemistry of AIDS. Annu Rev Biochem (1991) 3.06
Human immunodeficiency virus-like, nonreplicating, gag-env particles assemble in a recombinant vaccinia virus expression system. J Virol (1990) 2.58
The encephalomyocarditis virus internal ribosome entry site allows efficient coexpression of two genes from a recombinant provirus in cultured cells and in embryos. Mol Cell Biol (1991) 2.42
Nucleotide sequence of a full-length human endogenous retroviral segment. J Virol (1985) 2.36
Transfer of the bacterial gene for cytosine deaminase to mammalian cells confers lethal sensitivity to 5-fluorocytosine: a negative selection system. Proc Natl Acad Sci U S A (1992) 2.09
Role of the gag and pol genes of human immunodeficiency virus in the morphogenesis and maturation of retrovirus-like particles expressed by recombinant vaccinia virus: an ultrastructural study. J Gen Virol (1991) 2.05
Curability of tumors bearing herpes thymidine kinase genes transferred by retroviral vectors. J Natl Cancer Inst (1990) 1.99
Human serum lyses RNA tumour viruses. Nature (1975) 1.92
ERV3, a full-length human endogenous provirus: chromosomal localization and evolutionary relationships. Virology (1984) 1.92
A new class of endogenous human retroviral genomes. Science (1985) 1.89
Evidence for neurotoxic activity of tat from human immunodeficiency virus type 1. J Virol (1991) 1.75
Human endogenous proviruses. Curr Top Microbiol Immunol (1989) 1.68
HIV: to vaccinate or not to vaccinate? Nature (1992) 1.57
HIV with multiple gene deletions as a live attenuated vaccine for AIDS. AIDS Res Hum Retroviruses (1992) 1.36
Oncogenes at viral integration sites. Cell Growth Differ (1990) 1.31
A novel human nonviral retroposon derived from an endogenous retrovirus. Nucleic Acids Res (1987) 1.29
Ancestry of a human endogenous retrovirus family. J Virol (1989) 1.26
Human endogenous retroviruslike genome with type C pol sequences and gag sequences related to human T-cell lymphotropic viruses. J Virol (1987) 1.26
A model for predicting the risk of cancer consequent to retroviral gene therapy. Hum Gene Ther (1992) 1.14
Isolation of three kinds of human endogenous retrovirus-like sequences using tRNA(Pro) as a probe. Nucleic Acids Res (1987) 1.13
Endogenous retroviral elements in human DNA. Cancer Res (1990) 1.07
Improbability of effective vaccination against human immunodeficiency virus because of its intracellular transmission and rectal portal of entry. Proc Natl Acad Sci U S A (1992) 1.04
Highly immunogenic human immunodeficiency viruslike particles are produced by recombinant vaccinia virus-infected cells. AIDS Res Hum Retroviruses (1991) 0.85
The dilemma of AIDS vaccine and therapy. Possible clues from comparative pathogenesis with measles. AIDS Res Hum Retroviruses (1992) 0.83